Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative Surgery
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background We compared outcomes of surgery and radiofrequency thermal ablation (RFA) in patients with metachronous liver metastases.Methods Between October 1995 and December 2005, 59 patients underwent hepatic resection and 30 underwent RFA for metachronous liver metastases. Patients with extra-hepatic metastases, those who underwent both types of treatment, and those with synchronous hepatic metastasis were excluded.Results The two groups had similar mean age, sex ratio, comorbid medical conditions, primary disease stage, and frequency of solitary metastases. Preoperative mean serum carcinoembryonic antigen (CEA) level was significantly higher in the RFA group (13.4 ng/mL vs. 7.7 ng/mL; p = 0.02). Mean diameter of hepatic metastases was significantly greater in the resection than in the RFA group (3.1 cm vs. 2.0 cm; p = 0.001). Recurrence after treatment of metastasis was observed in 18 of 30 (60.0%) RFA and 33 of 59 (56%) resection patients. Local recurrence at the RFA site was observed in 7 of 30 (23%) patients. Time to recurrence (15 vs. 8 months, p = 0.02) and overall survival (56 vs. 36 months, p = 0.005) were significantly longer in the resection than in the RFA group. In the 69 patients with solitary metastases of diameter </=3 cm, time to recurrence (p = 0.004) and overall survival were significantly greater in the resection group.Conclusions Compared with hepatic resection, RFA for metachronous hepatic metastases from colorectal cancer was associated with higher local recurrence and shorter recurrence-free and overall survival rates, even in patients with solitary, small (</=3 cm) lesions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a high rate of recurrence in comparison to resection, however, and long-term survival is reported to be poor [46], so it is not recommended as an alternative to surgical resection [47] (CQ-12).”
From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [46]
Citations
Cites
Fong, Y., Fortner, J., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,715
Abdalla, E. K., Vauthey, J.-N., Ellis, L. M., Ellis, V., Pollock, R., Broglio, K. R., Hess, K., & Curley, S. A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128305.90650.71 · Cited by 1,750
Resection of colorectal liver metastases
Scheele, J., Stang, R., Altendorf‐Hofmann, A., & Paul, M. (1995) · World Journal of Surgery · doi:10.1007/bf00316981 · Cited by 1,539
Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases
Choti, M. A., Sitzmann, J. V., Tiburi, M. F., Sumetchotimetha, W., Rangsin, R., Schulick, R. D., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200206000-00002 · Cited by 1,454
Clemente, C. G., Mihm, M. C., Bufalino, R., Zurrida, S., Collini, P., & Cascinelli, N. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1303::aid-cncr12>3.0.co;2-5 · Cited by 1,171
Pawlik, T. M., Scoggins, C. R., Zorzi, D., Abdalla, E. K., Andres, A., Eng, C., Curley, S. A., Loyer, E. M., Muratore, A., Mentha, G., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000160703.75808.7d · Cited by 1,101
Solbiati, L., Livraghi, T., Goldberg, S. N., Ierace, T., Meloni, F., Dellanoce, M., Cova, L., Halpern, E. F., & Gazelle, G. S. (2001) · Radiology · doi:10.1148/radiol.2211001624 · Cited by 870
WAGNER, J. S., ADSON, M. A., VAN HEERDEN, J. A., ADSON, M. H., & ILSTRUP, D. M. (1984) · Annals of Surgery · doi:10.1097/00000658-198405000-00002 · Cited by 694
Indicators of prognosis after hepatic resection for colorectal secondaries.
Scheele, J., Stangl, R., Altendorf-Hofmann, A., & Gall, F. P. (1991) · PubMed · Cited by 564
Solbiati, L., Ierace, T., Goldberg, S. N., Sironi, S., Livraghi, T., Fiocca, R., Servadio, G., Rizzatto, G., Mueller, P. R., Del Maschio, A., et al. (1997) · Radiology · doi:10.1148/radiology.202.1.8988211 · Cited by 527
Research works printed but not linked: 1
- Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254–1262 · DOI · Paper page
Cited by
Japanese Society for Cancer of the Colon and Rectum, Watanabe, T., Muro, K., Ajioka, Y., Hashiguchi, Y., Ito, Y., Saito, Y., Hamaguchi, T., Ishida, H., Ishiguro, M., et al. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1101-6 · Cited by 2,467
“There is a high rate of recurrence in comparison to resection, however, and long-term survival is reported to be poor [46], so it is not recommended as an alternative to surgical resection [47] (CQ-12).”
BackgroundWatanabe, T., Itabashi, M., Shimada, Y., Tanaka, S., Ito, Y., Ajioka, Y., Hamaguchi, T., Hyodo, I., Igarashi, M., Ishida, H., et al. (2015) · International Journal of Clinical Oncology · doi:10.1007/s10147-015-0801-z · Cited by 590
“There is a high incidence of recurrence in comparison with resection, however, and long-term survival is reported to be poor [46], so it is not recommended as an alternative to surgical resection [47] (CQ-12).”
BackgroundMetastatic Colorectal Cancer: From Improved Survival to Potential Cure
Gallagher, D. J., & Kemeny, N. (2010) · Oncology · doi:10.1159/000315730 · Cited by 235
Meijerink, M. R., Puijk, R. S., van Tilborg, A. A. J. M., Henningsen, K. H., Fernandez, L. G., Neyt, M., Heymans, J., Frankema, J. S., de Jong, K. P., Richel, D. J., et al. (2018) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-018-1959-3 · Cited by 205
Ablative therapies for colorectal liver metastases: a systematic review
Pathak, S., Jones, R., Tang, J. M. F., Parmar, C., Fenwick, S., Malik, H., & Poston, G. (2011) · Colorectal Disease · doi:10.1111/j.1463-1318.2011.02695.x · Cited by 167
Metadata
- Authors
- Park, I. J., Kim, H. C., Yu, C. S., Kim, P. N., Won, H. J., & Kim, J. C.
- Affiliations
- University of Ulsan (KR)
- Corresponding author
- Kim, Hee Cheol
- Venue
- Annals of Surgical Oncology
- Published
- 2007-09-20
- Volume
- 15
- Issue
- 1
- Pages
- 227-232
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2002519662
- Cited by
- 112
- References
- 19
- Citations by year
- 2024: 4 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 11 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 6 · 2014: 14 · 2013: 9 · 2012: 15
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Annals of Surgical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Keywords
- radiofrequency ablation, metachronous liver metastases, colorectal cancer, hepatectomy, local recurrence, overall survival, carcinoembryonic antigen, recurrence-free survival
- MeSH terms
- Adult, Aged, Combined Modality Therapy, Female, Hepatectomy, Humans, Liver Neoplasms, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Retrospective Studies, Colorectal Neoplasms, Radiology, Interventional, Survival Rate, Treatment Outcome, Catheter Ablation, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative Surgery. https://app.cochat.ai/papers/10.1245/s10434-007-9625-z
- The paper
- Park, I. J., Kim, H. C., Yu, C. S., Kim, P. N., Won, H. J., & Kim, J. C. (2008). Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative Surgery. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-007-9625-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.